CLINICAL_TRIALS
trial_result
· 2012-03-07
Clinical Trial Update: Nexium Study To Suppress Nausea During Chemotherapy [Phase 3]
Summary
A Phase 3 clinical trial update for Nexium aimed at suppressing nausea during chemotherapy has been terminated, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Baylor Breast Care Center | Conditions: Nausea | Phase 3 | Status: TERMINATED | Results posted: 2012-03-07